June 2016: This quality standard was updated and statements prioritised in 2011 were replaced.
Statements are marked as [new 2016] or [2011, updated 2016]:
[new 2016] if the statement covers a new area for quality improvement
[2011, updated 2016] if the statement covers an area for quality improvement included in the 2011 quality standard and has been updated.
Statements numbered 5, 11, and 12 in the 2011 version have been updated and are included in the updated quality standard, marked as [2011, updated 2016].
Statements from the 2011 version (numbered 1–4, 6–10 and 13) that are no longer considered national priorities for improvement, but may still be useful at a local level, are included after the updated statements in the list of quality statements section.
The 2011 quality standard for breast cancer is available as a pdf.
Minor changes since publication
December 2018: Changes have been made to align this quality standard with the updated NICE diagnostics guidance on tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. Statement 3 was amended to reflect the different options for tumour profiling tests now recommended in the guidance. The source guidance was also updated.
July 2018: Changes have been made to align this quality standard with the updated NICE guideline on early and locally advanced breast cancer. References and source guidance sections have been updated.
August 2017: The rationale and source guidance details for statement 4 were updated and a definition added to ensure consistency with the NICE guideline on advanced breast cancer, which was updated in August 2017.
June 2017: Statements from the 2011 version that are no longer national priorities but may be useful locally have been moved to the list of quality statements section.